4//SEC Filing
Ma Songjiang 4
Accession 0001140361-25-009424
CIK 0001124105other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:01 PM ET
Size
7.2 KB
Accession
0001140361-25-009424
Insider Transaction Report
Form 4
Ma Songjiang
DirectorPresident
Transactions
- Sale
Common Stock
2025-03-17$12.09/sh−2,000$24,180→ 2,829,260 total(indirect: By Spouse) - Sale
Common Stock
2025-03-18$10.24/sh−242$2,478→ 2,829,018 total(indirect: By Spouse)
Footnotes (3)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.795 to $12.38. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.02 to $10.33. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
GYRE THERAPEUTICS, INC.
CIK 0001124105
Entity typeother
Related Parties
1- filerCIK 0001985547
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:01 PM ET
- Size
- 7.2 KB